Renaissance Capital logo

BHVN News

US IPO Weekly Recap: Biotechs and energy fail to excite in 5-IPO week

AMGP

Five IPOs raised $1.4 billion this week, bringing the year's total up to 50 IPOs raising $15 billion.  Set to be the week's largest offerings, two energy companies struggled: Antero Midstream GP broke issue while Liberty postponed. A mortgage REIT and three...read more

Migraine biotech Biohaven Pharmaceuticals prices upsized IPO above the range at $17

Biohaven Pharmaceuticals Holding logo

Biohaven Pharmaceuticals Holding, which is developing treatments for migraine and neurological disorders, raised $168 million by offering 9.9 million shares at $17, above the range of $14 to $16. Biohaven Pharmaceuticals plans to list on the NYSE under the...read more

US IPO Week Ahead: May starts strong with 6 IPOs featuring energy and biotech

AMGP

The IPO market continues to heat up with six deals on the calendar aiming to raise $1.7 billion in the first week of May. They include three biotechs, two energy companies and...read more

Rare disease biotech Biohaven Pharmaceuticals sets terms for $125 million IPO

Biohaven Pharmaceuticals Holding logo

Biohaven Pharmaceuticals, which is developing treatments for neurological diseases and rare disorders, announced terms for its IPO on Monday. The New Haven, CT-based company plans to raise $125 million by offering 8.3 million shares at a price range of $14...read more